imiquimod (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the imiquimod drug offered from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | imiquimod |
SUBSTANCE NAME: | IMIQUIMOD |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-02-25 |
END MARKETING DATE: | 0000-00-00 |
imiquimod HUMAN PRESCRIPTION DRUG Details:
Item Description | imiquimod from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
LABELER NAME: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/g) |
START MARKETING DATE: | 2010-02-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0168-0432_fdbbf340-e87c-44ed-9274-148846ffd788 |
PRODUCT NDC: | 0168-0432 |
APPLICATION NUMBER: | ANDA078548 |
Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers: